Advances in Breast Reconstruction
Transcription
Advances in Breast Reconstruction
Advanced Concepts in Breast Reconstruction: Minimizing and Managing Complications LifeCell Dinner Symposium Denver, Colorado Sunday, September 25th, 2011 Maximizing Technique to Minimize Complications Scot Bradley Glasberg, M.D. Cosmetic and Reconstructive Plastic Surgery New York, New York Important Information y y y y y y Dr. Glasberg is a speaker for LifeCell Corporation. Some sections of this presentation which contain case studies and clinical reports are based upon the surgeon’s clinical experience and research. Results may not be typical and individual results may vary. Please refer to the Essential Prescriber Information for product indications for use. Users should read and understand all Instructions for Use, including essential prescriber and safety information, prior to application of the product. For complete safety information and complete instructions for the proper use of the SPY® Elite System, please refer to the SPY® Elite System Operator’s Manual and SPY® Elite Kit Instructions for Use. The SPY® Elite System is to be used under the direction of a physician. The surgical techniques described herein are suggested techniques for using LifeCell Corporation Tissue Matrices. Proper surgical procedures and techniques are necessarily the responsibility of the medical professional. Each surgeon must evaluate the appropriateness of the technique based on his or her own medical training and expertise. The photographs contained in the presentations are the surgeon’s unless otherwise indicated. Trademarks used herein are trademarks of their respective owners. y y Consultant, Lifecell Corporation Consultant, Mentor Corporation ◦ Principal Investigator: x Mentor, Core Gel Silicone Implant Study x Mentor, CPG Cohesive Gel Implants Studies y y y y Consultant, Gerson Lehrman Group Consultant, Leerink Swann / Medacorp Consultant, Healthcor Inc. Interim Consultant, Ethicon / Johnson and Johnson Disclosures y y y y y y y June 2004 – October 2007 Lenox Hill Hospital/ Englewood Hospital / Beth Israel Medical Center 126 reconstructions 96 patients Average age = 44.5 y.o. Average length of followup = 18.18 months Biopsies taken at time of exchange y y y y y y y y AlloDerm Results 3 expander extrusions (2.4%) 0 major infections 0 mastectomy flap necrosis 3 local infections / cellulitis (2.4%) 16 seromas (12.7%) 2 hematomas (1.6%) 3 mild capsular contractures (all in previously radiated patients) (2.4%) [18 Localized redness / inflammation (selflimited) (14.3%)] y y y y y y y October 2007-present Lenox Hill Hospital / Beth Israel Medical Center Englewood Hospital 144 Reconstructions 90 Patients Average age = 42.6 y.o. Average length of followup = 14.4 months Biopsies taken at time of exchange y y y y y y y y 2 expander extrusions / loss * (1.4%) 0 major infections 2 mastectomy flap necrosis (1.4%) 3 local infection / cellulitis (2.1%) 2 seromas (1.4%) 0 hematomas 4 mild capsular contractures (all in previously irradiated patients) (2.8%) [18 localized redness / inflammation (selflimited) (12.5%)] Strattice (Pliable) Results y y y y y y 12 breasts previously radiated (9.5% of breasts) 1 expander extrusion (8.3%) 2 local infections / cellulitis (16.6%) 0 mastectomy flap necrosis 2 seromas (16.67%) 3 capsular contractures (25%) y y y y y y 21 breasts radiated postoperatively (16.67% of breasts) 1 expander extrusion (4.8%) 1 local infections / cellulitis (4.8%) 0 mastectomy flap necrosis 2 seromas (9.5%) 0 capsular contracture (0.0%) AlloDerm Results – Radiation (126 total breasts) y y y y y y 16 breasts previously radiated (11.1% of breasts) 1 expander extrusion (6.3%) 2 local infections / cellulitis (12.5%) 1 mastectomy flap necrosis 1 seromas (6.3%) 4 capsular contractures (25.0%) y y y y y y 27 breasts radiated postoperatively (18.75% of breasts) 1 expander extrusion (6.3%%) 1 local infections / cellulitis (6.3%) 0 mastectomy flap necrosis 0 seromas (0.0%) 0 capsular contracture (0.0%) Strattice Results – Radiation (144 total breasts) y Both preoperative and postoperative radiation treatment adds statistically significant increased risk of complications y AlloDerm and Strattice may be used effectively in two-stage breast reconstructions involving radiation y Surgeons should seriously consider autogenous forms of reconstruction if radiation was undertaken preoperatively or known to be needed postoperatively Discussion Points - Radiation y Careful technical considerations ◦ Preoperatively ◦ Intraoperatively ◦ Postoperatively y General vs. Technique-Specific considerations What Leads to Good Outcomes? General Considerations Endogenous versus Exogenous Risk Factors y y y y y y y y Tobacco and Alcohol use Poor Nutrition Obesity Diabetes / hyperglycemia Oxygen Saturation levels Hypothermia Remote Site Body Infection Colonization with Microorganisms Endogenous Risk Factors y y y y Smoking one cigarette lowers wound and tissue PO2 by 30% for greater than 1 hour Delays primary healing Is associated with Surgical Site Infections Encourage cease tobacco use at least one month pre-surgery ◦ includes cigarettes, cigars, pipes, chewing tobacco ◦ And postoperatively as long as possible y Jensen JA Arch Surg 126:1131-1134, 1991; CDC/HICPAC 1999 Prevention of SSI Smoking y Alcohol reduces effectiveness of immune system, hampering: ◦ Neutrophils, Dendritic cells, Natural Killer (NK) cells, B cell responses, general capacity to clear infectious agents ◦ Barrier functions of skin, lung, and intestine Waldschmidt TJ. Alcohol. 2008 Mar;42(2):137-42 y 717 surgical patients observed for SSI or pneumonia ◦ 14.8% of nondrinkers acquired infection ◦ 25% of those who consumed 109g -144g alcohol/day y News release, Hoboken, NJ: John Wiley & Sons, Inc, British Journal of Surgery, Oct 21, 2003 Alcohol y Malnutrition associated with increased rate of post-op complications: complications ◦ ◦ ◦ ◦ incision dehiscence impaired wound healing infection delayed gastrointestinal emptying ◦ recovery Physical Examination Usually assessed by levels of: – – – – albumin prealbumin transferrin Total lymphocyte count Klein JD.Spine 1996; 21(22): 2676-82;;Surgery: Basic Science and Clinical Evidence Ed. Norton JA. Et. al. 2008 Springer Press. New York, NY Nutrition y y Defined at >20% over ideal body weight US adult elective surgery patient: ◦ 37% overweight ◦ 17% severely over-weight y Weight alters ◦ hemostatic balance ◦ immune function Obesity y y Interfere with epidermal regeneration and collagen synthesis leaving the healing incision more vulnerable to infection Reduced resistance to infection ◦ system wide if given systemically ◦ locally if injected near the site of surgery y y Gradually taper use prior to surgery if possible Much forgotten intervention: ÆHigh Dose Vitamin A Steroids y Macro and micro vascular damage y Neutrophils at various levels of dysfunction y May also have ◦ glycosylated hemoglobin ◦ impaired complement cascade ◦ impaired antibodies x reduces antibody assisted cytotoxicity x reduces opsonic potential and phagocytosis y Control blood glucose levels preoperatively ◦ glucose below 200mg/dL (Some advise tight control below 100mg/dL) ◦ adjust intra-operatively for longer procedures ◦ continue at least 24 hours post-operatively y Continuous Insulin better than intermittent insulin ◦ Multiple studies confirm lower rate of SSI Diabetes y Pre-existing Conditions of concern ◦ COPD, Smoker, Lung Cancer, Chronic Bronchitis etc. y Reduced tissue oxygen resulting from obesity, diabetes, heart disease, respiratory insufficiencies, iatrogenic tissue ischemic events, hypothermia, tissue damage or other hypoxic events reduce wound defenses and ability to heal y O2 needed for: macrophage mobility neutrophil oxidative killing collagen deposition (scar strength) in-growth of granulation tissue fighting anaerobic infections (e.g. Clostridia Oxygen Saturation Levels y Reduced risk of infection with supplemental oxygen Example: 500 colorectal procedures: Two groups: Inspired oxygen during & two hours post-surgery: A. 30% inspired O2 B. 80% inspired O2 = 50% lower rate of infection Grief R Supplemental perioperative oxygen to reduce the incidence of wound infection. NEJM. 2000; 342 (3):161-7 Supplemental Oxygen y pre-surgery fasting y relaxant-premedication y prep solution cold and evaporating y cold surfaces, thin gown y high air turn-over filtration (windy) y anesthesia reducing metabolism y open wound vaporative heat y cold irrigants and restorative fluids Hypothermia – Heat loss? Just 1.5°C below normal: y y y y y y y increased wound infections (SSI) decreases O2 tension in tissues cardiac dysfunction coagulopathy/increased blood loss altered drug metabolism delayed recovery of normothermia increased mortality y Mahoney CB. AANA Journal 1999;67(2): 155-164.; Sessler DI. Clinics of America 1994;12(3): 425-456; Tammelin A. Infect Control Hosp Epidemiol 2001 Jun22(6): 338-346 Complications of Hypothermia Invasive Non-Invasive Intravascular heating catheter Warmed bypass blood Warmed irrigation fluids Hydrogel thermal pads Hot forced air closely fitted Hot water mattress/blanket Hot air hose (bad practice) Adjust room temperature Infrared lamps or thermal ceiling Multiple layers of blankets Plastic bags, paper drapes Warming prep solutions Operative Recommendation – Maintain Normothermia >36 >96.8 Hypothermia – Reduce Risk y Endogenous Sources – Patient ◦ Remote infection ◦ Normal skin flora y Exogenous Sources ◦ ◦ ◦ ◦ Surgical Team Environment Non-sterile instruments Organ / Tissue donations Microbial Contaminants – where come from? y y Do not remove hair unless absolutely necessary to perform procedure If removing, do so with clippers immediately prior to surgery Razor abrades skin = niches for microbial colonization Hair Removal – reduce risk Hair removed by razor night before 5.6% y Hair not removed or removed by depilatory 0.6% y Razor >24 hours prior to surgery >20.0% y Razor < 24 hours prior to surgery 7.1% y Razor immediately prior to surgery 3.1% y Clippers night before surgery 4.0% y Clippers right before surgery 1.8% y 1.) Seropian,R Am J Surg 1971;121;2511971;121;251-4 2.) Alexander JWArch Surg 1983;118(3) ;347;347-52; etal. 3.) Hamilton HW Can J Surg 1977;20:26971,2745; Also all in CDC Guide for the Prev Of SSI 1977;20:269 71,274 SSI Related to Hair Removal y Use an appropriate Skin Prep, antiseptic solution ◦ initial bacterial kill ◦ residual antimicrobial activity ◦ technique: concentric circle going outward * ◦ prep enough area to allow for enlarged incision or drain insertion ◦ prep “dirty” areas last (e.g. umbilicus) ◦ let dry – do not wipe off ◦ do soak-up pooled solutions drained off patient ◦ do not drape before dry OR Skin Preparation MEAN REDUCTION IN SKIN BACTERIA 0% Liquid Soap Povidone-Iodine Liquid Soap Chlorhexidine Detergent 90% Povidone-Iodine Solution Hexachlorophene Detergent Isopropanol 70% 99% Isopropanol 79% & Chlorhexidine 99.9% 0 1 2 3 TIME AFTER DISINFECTION (HOURS) Skin Prep Efficacy: Immediate and Residual Kill Proper ventilation Lint-free gowns, towels, drapes Appropriate attire – washed scrubs Decrease staff traffic in OR – limit to those involved in the surgery y Clean and sterilize all equipment y y y y ◦ Lights, loops etc. y y y Duration of Surgery <6 hours Minimize tissue trauma DO NOT USE POWDERED GLOVES Exogenous Sources – How to Decrease? y y y y y y Amplified inflammation Poor wound healing, scar formation Granulomas Blood clots Adhesions Infections Debris in the Surgical Wound Healthy Fibroblast Cells Same cells after suspension fluid Touched with sterile powdered glove Technique-Specific Considerations y y y y y Malposition Seroma Infection Flap Necrosis Is Redness Alone an Infection/ Complication? Potential Complications y y Proper Insetting of AlloDerm/Strattice is key ‘Reinforcing the Pocket’ – 3 zones ◦ Release medial pectoral insertions ◦ Proper inframmamary fold placement x Chest wall versus breast flap ◦ Lateral soft tissue support Malposition Inframmary Fold Control y Subpectoral pocket raised ◦ Entire inferior border of pectoralis elevated Intraoperative Technique y AlloDerm sewn to either breast flap or chest wall ◦ Dermal side out Intraoperative Technique AlloDerm – Polarity / Orientation Intraoperative / Inset y Dermal matrices appear to be associated with increased risk of seroma formation ◦ Possible explanations: repopulation, absorption of basement membrane y y y y y Associated axillary dissection Increased use of cautery Previous surgery – i.e. lumpectomy Previous radiation therapy Concomitant procedures – i.e. capsulectomy Seroma – Risk Factors y Seroma prevention = proper drainage and management y Length of drainage y Proper Placement of Drains y Proper treatment of Seroma Seroma y At least one drain between breast flaps and muscle/AlloDerm ◦ If any concern use two drains y Expand intraoperatively ◦ Goal = Direct Apposition x Risks: Too little -Æ seroma Too much -Æ flap necrosis Proper Drain Placement y Comfortable, yet maximal expansion at time of surgery – Direct Apposition ◦ ◦ ◦ ◦ y Avoid undue stress on skin flap Minimize dead space Maximize adherence of AlloDerm to skin flap Produce an immediate breast mound Sufficient tension on the AlloDerm to preserve breast shape: ◦ AlloDerm likely does not expand as compared to the pectoralis muscle y Closure with pectoralis deep to the incision is preferred How Much to Expand Intraoperatively? y Leave drains in place until <30cc./day ◦ May last 3-4 weeks y If drainage does not stop by week #2 ◦ Start expansion with drain in place Drain Maintenance (algorithm) y Common method – seroma aspiration Proper Treatment of Seroma y Closed system drainage Proper Treatment of Seroma y Use antibiotic irrigation for all procedures (1L NS mixed with 100,000 units Bacitracin, 80 gms. Gentamycin and 1 gm. Ancef) y Single perioperative dose of Ancef or equivalent (Surgical Care Improvement Project [SCIP]) within one hour of surgery ◦ Excellent randomized prospective data ◦ Being advocated by multiple Departments of Health and/or State Medical Boards y Do not leave patients on antibiotics as long as drains are in y New Antibiotic Concept = ‘less is more’ Infection – Antibiotic Usage y Just one key: y Early operative intervention Flap Necrosis y y y ‘Red Breast Syndrome’ Usually only represents inflammatory response Patients placed on oral antibiotics ◦ Probably not necessary y y y Not all expanders must or should be explanted AlloDerm orientation appears important Appears to correlate with cellular repopulation – AlloDerm vs. Strattice Breast Flap Redness Good Technique = Good Result y y y y y y y y Refined techniques over prolonged period of time Always prolonged soak (saline only) Use antibiotic irrigation for all procedures (1L NS mixed with 100,000 units Bacitracin, 80 gms. Gentamycin and 1 gm. Ancef) Breast surgeons rarely perform nipple-sparing mastectomies – inoculation When doing Nipple-Areola Sparing Mastectomy cover nipple with Tegaderm Never use powdered gloves – foreign nidus One-touch technique Cover the wound with Dermabond - sealed TECHNICAL PEARLS y y y y y y y SCIP (Surgical Care Improvement Project) Antibiotic Protocol – started 1/08 ◦ Single perioperative dose Form fitting surgical bra Biopatch – drain insertion site Surgeon does the surgery – less variability Prep used – not betadine, chlorhexidine / alcohol mix (Chloraprep) Wipe wound with alcohol Definition of infection ◦ ‘Red Breast Syndrome’ Technical Pearls – Few More Competitive Products ‘The Truth is Out There’ y Regenerative products ◦ ‘It’s all about the science’ y Any clinical data? ◦ Has tissue been used in humans? ◦ Are there any animal studies? xWhat species? Basic Concepts / Questions y How is tissue processed? y Does process lead to cross-linking of collagen? ◦ Prevents cellular ingrowth Basic Concepts (continued) y What does ‘safety’ (Sterility) really mean? ◦ Human Tissue Standards x>1,200,000 pieces of AlloDerm® implanted without any issues ◦ 510k – terminally sterilized xViral inactivation xDecreased bioburden y Histology ◦ “Show me the money” Basic Concepts (continued) Impact of Processing on Matrix Characteristics: Structure Skin Intact Collagen Cross-linking Chemical-Induced Cells Loss of Collagen Confidential 57 Pre-Implant Histology Preservation of the Matrix Preimplant Histology Competitive Product Explant Histology AlloDerm Æ Regeneration Explant Histology Competitive Product (cross-linked) Explant Histology Competitive Product (non cross-linked) Just One More! y y Raise your hand and a microphone will be passed to you Please state your name and where you are from Questions Thank You